Skip to main content

Open Access Publications from the University of California

Search eScholarship

Refine Search

All of eScholarshipThis Series

UCLA

UCLA Previously Published Works banner

Menu

About eScholarship
UC Open Access Policies
Journals
Academic Units

eScholarship
UCLA
UCLA Previously Published Works

This item is not available for download from eScholarship

Share

PARP inhibitor maintenance for primary ovarian cancer – A missed opportunity for precision medicine

2021

Wethington, Stephanie L;
Wahner-Hendrickson, Andrea E;
Swisher, Elizabeth M;
Kaufmann, Scott H;
Karlan, Beth Y;
Fader, Amanda Nickles;
Dowdy, Sean C
et al.

Published Web Location

https://www.ncbi.nlm.nih.gov/pubmed/34391577

No data is associated with this publication.

Creative Commons 'BY' version 4.0 license

Item not freely available? Link broken?

Report a problem accessing this item

Related Items

Pan-Cancer Analysis of Postdiagnosis Exercise and Mortality.
PGC-1α drives small cell neuroendocrine cancer progression toward an ASCL1-expressing subtype with increased mitochondrial capacity.
Loss-of-function in RBBP5 results in a syndromic neurodevelopmental disorder associated with microcephaly.
Staggered immunization with mRNA vaccines encoding SARS-CoV-2 polymerase or spike antigens broadens the T cell epitope repertoire.
Health care transition rates and associated factors for adolescents with asthma.

Home
About eScholarship
Campus Sites
UC Open Access Policy
eScholarship Publishing
Accessibility
Privacy Statement
Site Policies
Terms of Use
Admin Login
Help

Powered by the
California Digital Library
Copyright © 2017
The Regents of the University of California